Veterinary Medicines

Norvax Compact PD Emulsion for Injection for Atlantic Salmon

Not authorised
  • Salmon pancreas disease virus, strain F93-125, Inactivated
Download as PDF

Product identification

Medicine name:
Norvax compact PD emulsion for injection for Atlantic salmon
Norvax Compact PD Emulsion for Injection for Atlantic Salmon
Active substance:
  • Salmon pancreas disease virus, strain F93-125, Inactivated
Target species:
  • Atlantic salmon
Route of administration:
  • Intraperitoneal use

Product details

Active substance and strength:
  • Salmon pancreas disease virus, strain F93-125, Inactivated
    50118700.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intraperitoneal use
    • Atlantic salmon
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI10AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Expired
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • Bottles of polyethylene terephthalate (PET) closed with a rubber stopper and aluminium cap. Pack size: 250 ml (2,500 doses).
  • Bottles of polyethylene terephthalate (PET) closed with a rubber stopper and aluminium cap. Pack size: 500 ml (5,000 doses).

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • MSD Animal Health UK Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm 01708/3037
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0257/001